Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

The pace of technological innovation over the past three decades has transformed the field
of radiotherapy into one of the most technologically intense disciplines in medicine …

Vaginal cancer is a rare cancer. A lot of the data used in the treatment of this cancer are
extrapolated from cervical cancer data. Radiation therapy plays a significant role in the …

Introduction Delays in cancer diagnosis arose from the commencement of non-
pharmaceutical interventions (NPI) introduced in the UK in March 2020 in response to the …

Cervical cancer is one of the most common cancers in developing nations. It has had a
tremendous impact on the lifetime of millions of women over the last century and continues …

The purpose of this study was to determine if radiation (RT)-resistant cervical cancers are
dependent upon glutamine metabolism driven by activation of the PI3K pathway and test …

Primary vaginal cancer is a rare cancer and clinical evidence to support recommendations
on its optimal management is insufficient. Because primary vaginal cancer resembles …

Summary Background Resource-stratified guidelines (RSGs) can inform systemic treatment
decisions in the face of limited resources. The objective of this study was to develop a …

Purpose Randomized controlled trials (RCTs) are the cornerstone of delivering sustained
improvements in cancer outcome. To inform radiation therapy research policy and …

The leucine-rich repeat-containing G-protein-coupled receptor 6 (LGR6) is considered to be
a stem cell marker in many normal tissues and promotes tissue development, regeneration …